Photo of Katherine M. Clark
D United States House · District 5 · Massachusetts On the 2026 ballot

Rep. Katherine M. Clark

Compare
Total votes
2,837
all sessions
Attendance
100%
5 missed
Higher than 96% of chamber peers
With party
99%
of cast votes
Higher than 96% of chamber peers
Bipartisan score
1%
crosses aisle rarely
Lower than 96% of chamber peers
Sponsored
382
bills & resolutions
Lower than 99% of chamber peers
Committees
0
assignments
382 bills and resolutions

Sponsored bills

Total
382
Primary
23
Co-sponsor
359
This page
382
matching current filters
Co-sponsor HRES 942
In committee · United States House · Co-sponsor
Original Black History Month Resolution of 2022

Original Black History Month Resolution of 2022 This resolution recognizes the importance of commemorating Black History Month to acknowledge the achievements of Black Americans throughout history.

In committee Feb 25, 2022 1 co-sponsor
Co-sponsor HRES 915
In committee Feb 9, 2022 1 co-sponsor
Primary HR 6666
In committee · United States House · Lead sponsor
Higher Education Access and Success for Homeless and Foster Youth Act of 2022

Higher Education Access and Success for Homeless and Foster Youth Act of 2022 This bill requires certain actions to support access to higher education for children and youth who are homeless or in foster care. Among other provisions, the bill requires institutions of higher education (IHEs) participating in financial aid programs to give priority to these students for any on-campus housing during and between academic terms. Further, the bill requires IHEs to designate a staff liaison to assist these students with support services, programs, and community resources in a variety of areas, including financial aid and housing. The bill also requires these students to receive in-state tuition rates at public IHEs. Under current law, some states offer these students in-state tuition or provide them with tuition waivers.

In committee Feb 9, 2022 0 co-sponsors
Co-sponsor HR 3485
Passed · United States House · Co-sponsor
Global Respect Act

Global Respect Act This bill imposes visa-blocking sanctions on foreign persons responsible for or complicit in violating the human rights of individuals due to actual or perceived sexual orientation, gender identity, or sex characteristics. The President must report and periodically update a list of foreign persons responsible for such human rights violations and apply sanctions accordingly. The Department of State must designate at least one senior officer who shall be responsible for tracking violence and discrimination against individuals based on actual or perceived sexual orientation, gender identity, or sex characteristics in foreign countries.

Passed Feb 9, 2022 1 co-sponsor
Co-sponsor HRES 890
In committee · United States House · Co-sponsor
Recognizing the cultural and historical significance of Lunar New Year in 2022.

This resolution recognizes the cultural and historical significance of the Lunar New Year. The resolution expresses, in observance of this Lunar New Year, the Year of the Tiger, the deepest respect of the House of Representatives for Asian Americans and all individuals throughout the world who celebrate this significant occasion. The resolution wishes Asian Americans and all individuals who observe this holiday a happy and prosperous new year.

In committee Jan 28, 2022 1 co-sponsor
Co-sponsor HR 6525
In committee · United States House · Co-sponsor
Lunar New Year Day Act

Maddy summaryHR 6525, the Lunar New Year Day Act, would designate the Lunar New Year as an official federal holiday. The bill amends Section 6103(a) of Title 5 of the U.S. Code to add "Lunar New Year Day" to the list of holidays observed by federal employees. This holiday would be observed on the actual date of the Lunar New Year, which varies annually based on the lunar calendar. As a result, federal employees would receive a paid day off, and federal agencies would adjust operations to accommodate the new holiday.

In committee Jan 28, 2022 1 co-sponsor
Co-sponsor HR 6117
In committee · United States House · Co-sponsor
PrEP Access and Coverage Act

PrEP Access and Coverage Act This bill requires private health insurance plans to cover prescription drugs that prevent HIV, including related screenings, diagnostic procedures, administrative fees, and clinical follow-ups, without any cost-sharing obligation for the plan holder. Further, insurance plans must not impose any preauthorization requirement for this coverage. These coverage requirements also apply to public health insurance programs, including Medicare, Medicaid, and the Children's Health Insurance Program. Additionally, the bill prohibits denying, limiting, or qualifying coverage or increasing premiums for disability insurance, long-term care insurance, or life insurance policies based on an individual taking medication for HIV prevention. The bill further requires the Department of Health and Human Services to award grants to states, or directly to eligible local organizations, to provide uninsured individuals and underinsured individuals access to prescription drugs and related services that prevent HIV. The Centers for Disease Control and Prevention also must develop a public awareness campaign that focuses efforts in communities with a high need for HIV prevention treatment.

In committee Jan 6, 2022 1 co-sponsor
Co-sponsor HR 3537
Signed into law · United States House · Co-sponsor
Accelerating Access to Critical Therapies for ALS Act

Accelerating Access to Critical Therapies for ALS Act This bill establishes grant programs to address neurodegenerative diseases, such as amyotrophic lateral sclerosis (also known as ALS or Lou Gehrig's disease), and contains other related provisions. The Department of Health and Human Services (HHS) shall award grants to eligible entities for scientific research utilizing data from expanded access to investigational ALS treatments for individuals who are not otherwise eligible for clinical trials.  The Food and Drug Administration (FDA) shall award grants to public and private entities to cover the costs of research and development of drugs that diagnose or treat ALS and other rare neurodegenerative diseases. HHS shall also establish the Public-Private Partnership for Neurodegenerative Diseases between the National Institutes of Health, the FDA, and at least one eligible entity (generally, an institution of higher education or a nonprofit organization). The partnership shall support the development and regulatory review of drugs that address ALS and other rare neurodegenerative diseases. The FDA shall publish on its website a five-year action plan for fostering the development of drugs that improve or extend the lives of people living with rare neurodegenerative diseases. The Government Accountability Office must report to Congress about the grants provided under this bill, including an analysis of the impact of such grants on research and development of treatments for ALS.

Signed into law Dec 23, 2021 1 co-sponsor
Showing 201 to 210 of 382 bills
Previous 1 … 20 21 22 … 39 Next